Fact CheckerSign in

NCT03737045Completed

Psoriatic Arthritis and Psoriasis Treatment Decision Aid

Developing a Patient-centered Patient Decision Aid for Psoriasis and/or Psoriatic Arthritis Using Design Thinking.

Source: ClinicalTrials.gov · Last updated 17 Feb 2026

Brief summary (registry, in English)

The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.

Status (registry)
Completed
Study type
Interventional
Enrollment
37 (actual)
First submitted
31 Oct 2018
Start date
1 Dec 2018
Primary completion date
31 Dec 2025
Lead sponsor
University of Pennsylvania
NCT number
NCT03737045

What you commit to

  • Study type: Interventional
  • Participants enrolled: 37
  • From 1 Dec 2018 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Not starting or switching to a new medication

Age

  • Youth, under the age of 18 years

Other

  • Unable to give informed consent
  • Patients without psoriasis or psoriatic arthritis
  • Not being treated at a Penn clinic
    • In addition to the above, for the observation and implementation phases of the study:

Who the study is looking for

  • Age 18 years or older
  • Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist)
  • Treated at Penn
    • In addition to the above, for the observation and implementation phases of the study:
  • Initiation of a new psoriasis or psoriatic arthritis treatment
    • Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation
    • Patients may be taking other traditional DMARDs.
    • A washout period is not required.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital at the University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.